Qualigen Therapeutics Inc (NAS:QLGN)
$ 0.1645 0.0077 (4.97%) Market Cap: 4.45 Mil Enterprise Value: 5.82 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Ritter Pharmaceuticals, Inc. - Special Call Transcript

Feb 20, 2019 / 06:00PM GMT
Unidentified Participant

So doctor, thank you very much for taking the time for this call today. I'm looking forward to hearing your thoughts on the space. For compliance purposes, I'd like to confirm a few points, which I'll read through, and you can grant your verbal consent at the end, okay?

William D. Chey
Ritter Pharmaceuticals, Inc. - Member of Medical Advisory Board

Sure.

Unidentified Participant

Great. So first, this call is being recorded and transcribed. Second, you, the expert, attest that you will not disclose any confidential and material nonpublic information. And finally, you attest that if you're a physician and participating in our clinical trial, you will not discuss any information not yet in the public domain. If you're a member of a scientific advisory board, clinical trial steering committee and/or data safety monitoring board, you will not disclose any information that is not publicly available or information that will break any confidentiality agreements by which you are bound? Do you agree to these terms

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot